MAT combines medications with counseling and behavioral therapies to address withdrawal symptoms and cravings while supporting recovery.
Methadone is a long-acting opioid agonist that helps reduce cravings and withdrawal symptoms in individuals with opioid addiction.
Naloxone is an opioid antagonist that rapidly reverses opioid overdose effects, including respiratory depression.
Acamprosate helps reduce cravings and supports abstinence in individuals recovering from alcohol dependence.
Buprenorphine acts as a partial opioid agonist, reducing misuse risk, while methadone is a full agonist and requires stricter monitoring.
Naltrexone is an opioid antagonist that prevents opioids from binding to receptors, blocking their euphoric and sedative effects.
Naltrexone is approved for treating both alcohol and opioid use disorders, helping to reduce cravings and prevent relapse.
Advertisement
Naltrexone is approved for treating both alcohol and opioid use disorders, helping to reduce cravings and prevent relapse.
Disulfiram causes adverse effects like nausea and vomiting when alcohol is consumed, acting as a deterrent to drinking.
Educating patients ensures they use medications safely, adhere to treatment, and are aware of possible side effects or interactions.
Nicotine addiction is often treated with medications like varenicline and nicotine replacement therapy to reduce cravings and withdrawal symptoms.
